Share price
$56.73
−4.19% · −$2.48
Open $56.24 · Range $54.07–$57.75
SharonAI Shares Drop 4.2% After Nvidia Halts Financing, Leaving $4.88 Billion Deal in Limbo
NEW YORK, August 28, 2026, 11:13 – SharonAI shares slid 4.2% as uncertainty grew over its $4.88 billion deal with Nvidia, following Nvidia's decision to suspend financing arrangements.
NASDAQ: SHAZ · Stock move
SharonAI financing-risk dashboard
A contract-heavy AI infrastructure story meets a tougher funding signal.
Market data: Aug. 28, 2026
10:53:32 EDT
10:53:32 EDT
Market value
$1.064B
≈$47M erased
Implied from current cap and session move
Volume
729,246
Shares traded by 10:53:32 EDT
Nvidia agreement
$4.88B
Maximum six-year contract value
Scale mismatch
Contracts lead recognized revenue by years
Total contract value is an operating measure across multi-year terms. It is not GAAP revenue.
Catalyst
Nvidia financing pause
Reuters reported Nvidia paused some credit-support deals that exchanged financing help for cloud-revenue participation.
Program <2 months old
Antitrust concern
May be revamped
Nvidia said the broader compute-access model remains in place and continues to evolve.
Q2 2026 snapshot
| Metric | Value | Signal |
|---|---|---|
| Revenue | $1.93M | +412% YoY |
| Adjusted EBITDA | $0.59M | Positive |
| Net loss | −$430.4M | Mostly non-cash |
| Cash | $1.861B | Build-out buffer |
| Current note liabilities | $1.007B | Financing weight |
Contract conversion watch
| Checkpoint | Why it matters |
|---|---|
| Financing terms | Determines deployment cost and equity dilution |
| GPU acceptance | Triggers capacity availability and revenue |
| Customer utilization | Turns reserved capacity into billed sales |
| Contract amendments | Tests whether Nvidia's pause reaches SharonAI |
| Cash burn | Measures runway during infrastructure ramp |
Sensitivity map
What changes the equity case?
Investor read
The stock move values implementation risk, not simply demand. SharonAI's SEC filing already says deployments need additional debt or equity financing and face phased acceptance tests.
Key question: can $8.8 billion of contracted value convert into revenue without costly new capital?
BioNTech Shares Drop 6.6% After Board Terminates Colorectal Cancer Vaccine Study
BioNTech SE American depositary shares dropped 6.6% on Friday following the company’s decision to halt a Phase 2 study of autogene cevumeran. The individualized mRNA immunotherapy was under evaluation post-surgery for patients with high-risk colorectal cancer.
BNTX investor dashboard
One cancer program stops; the cash-rich platform remains
Market data: Aug. 28, 2026, 10:05 EDT
Financial data: June 30, 2026
Financial data: June 30, 2026
BNTX price
$104.09
−6.56%
Value erased
≈$1.8bn
251.2m June shares
Q2 R&D
€551m
5.2× Q2 revenue
Cash + securities
€16.63bn
Strong redirection capacity
Opening reaction
The ADSs opened at $102.34, traded as low as $98.80, then recovered part of the decline.
What changed
Phase 2 autogene cevumeran colorectal-cancer monotherapy study will terminate.
The monitoring board found a numerical overall-survival imbalance between arms and judged further continuation unlikely to change efficacy.
Stage II high-riskStage IIIctDNA-positivePost-surgeryPipeline event versus financial capacity
| Measure | Latest | Investor signal |
|---|---|---|
| Q2 revenue | €105.6m | Down 59.5% year over year |
| Q2 R&D expense | €551.0m | Heavy oncology investment continues |
| Q2 net loss | €820.8m | Up 112% year over year |
| 2026 revenue guide | €1.6–€1.9bn | Already reduced in August |
| 2026 adjusted R&D guide | €2.0–€2.3bn | Capital allocation becomes more important |
| Share repurchase authorization | Up to $1.0bn | Potential downside buffer, market-dependent |
Scale comparison
Liquidity can absorb program failure, but repeated negative readouts would compress pipeline valuation.
Analyst expectations
| Consensus | Buy |
| Average target | $121.51 |
| Median target | $129.75 |
| Low / high | $76.14 / $145.26 |
| Coverage | 20 analysts |
Snapshot checked Aug. 28; ratings predate the trial termination.
Watch next
Detailed trial disclosureOther autogene cevumeran programsOncology portfolio reprioritizationNov. 3 Q3 updateBull case: the stop saves future study spending and cash is redirected to stronger assets. Bear case: the survival signal weakens confidence in personalized mRNA oncology and raises scrutiny across partnered programs.
Moderna Slides 3.4% After $2.6 Billion Convertible Offering Challenges Post-Cancer-Vaccine Surge
CAMBRIDGE, Massachusetts, August 28, 2026, 09:47 - Moderna shares declined by 3.4% as the company launched a $2.6 billion convertible bond offering, putting its recent rally following positive news on its cancer vaccine under scrutiny.
MRNA investor dashboard
Zero-coupon capital, real dilution math
Market data: Aug. 28, 2026, 09:46:51 EDT
Company data: June 30, 2026 unless noted
Company data: June 30, 2026 unless noted
Share price
$137.86
−3.44%
Intraday range
$134.07–$147.77
5.54m shares
Note principal
$2.60bn
0.00% coupon
Market value
$54.77bn
≈$2.0bn erased
Friday's opening repricing
Reference points: $137.25 open, $147.77 high, $134.07 low, $137.86 latest.
Why the market hesitated
Initial conversion equals roughly 3.1% of the June share base. The capped call is designed to offset dilution, but only up to its cap.
2032 maturityRule 144ASenior unsecuredDeal mechanics
| Measure | Term | What it changes |
|---|---|---|
| Initial conversion | $210.58 | 47.5% premium to Thursday close |
| Capped-call ceiling | $392.6175 | Hedge protection to 175% premium |
| Expected net proceeds | $2.563bn | About 37% of June liquidity |
| Capped-call cost | $285m | About 11% of base net proceeds |
| Buyer option | Up to $400m | Could lift net proceeds near $2.96bn |
Operating runway context
The financing replenishes flexibility after the settlement payment and ongoing research spending.
Commercial and valuation signals
| Q2 revenue | $145m |
| Q2 EPS | −$1.97 |
| 2026 revenue plan | Up to +10% |
| Year-end cash guide | $4.7–$5.2bn |
| Analyst consensus | Hold |
| Average target | $106.63 |
Next checkpoints
Sept. 1: expected note closingComing days: updated vaccines availableAutumn: U.S. respiratory seasonNov. 12: analyst dayBull case: zero-coupon funding protects oncology momentum and the hedge limits dilution. Bear case: the stock remains above consensus value while cash burn and vaccine demand stay uncertain.
Roivant Shares Slide 2.7% Following LISRAYA Approval, Eyes Turn to $2 Billion Revenue Target
Shares in Roivant Sciences Ltd. lost 2.7% on Friday, despite receiving U.S. regulatory approval for LISRAYA. The decline wiped out roughly $720 million in implied equity value.
LISRAYA approval: commercialization replaces regulatory risk
Roivant Sciences (NASDAQ: ROIV) · Market data at August 28, 2026, 09:39:23 EDT
ROIV price
$36.58
−2.66% · −$1.00
Market value
$26.42B
722.32M shares outstanding
Peak U.S. sales
>$2B
JPMorgan estimate, early 2030s
Implied value erased
~$722M
$1.00 decline × reported shares
Price context
| Previous close | $37.58 |
| Friday open | $37.01 |
| Early range | $36.49–$37.13 |
| 52-week range | $11.85–$37.95 |
| Average volume | 5.36M shares |
VALOR Phase 3 readout
| Measure | LISRAYA 30mg | Placebo |
|---|---|---|
| Mean TIS, week 52 | 46.5 | 31.2 |
| Advantage | +15.3 points | — |
| Treatment discontinuation | 6% | 11% |
| Trial size | 241 adults; 52 weeks | |
Valuation bridge
Peak-sales estimate as a share of current equity value
7.6% · $2.0B / $26.42B
Funding and burn
| Cash and securities, June 30 | $3.9B |
| Quarterly net loss | $290.6M |
| Quarterly R&D | $202.0M |
| Quarterly revenue | $1.4M |
| Share repurchases | $208.7M |
Catalyst map
| Event | Status | Investor test |
|---|---|---|
| FDA approval | Completed Aug. 27 | Regulatory risk removed |
| Specialty-pharmacy launch | Immediate | Prescription conversion |
| Pricing disclosure | Pending | Gross-to-net revenue |
| Payer coverage | Developing | Launch velocity and access |
Risk monitor
Pricing remains undisclosed. Payer restrictions could slow uptake in a small patient population. LISRAYA carries boxed warnings for serious infections, malignancy, major cardiovascular events and thrombosis.
Sources: FDA, Roivant, Reuters, Roivant quarterly results and Google Finance. Trial and financial data are company-reported unless noted.
Elastic shares surge 17.4% as $1.85 billion RPO boosts outlook
Shares of Elastic N.V. rose 17.4% in premarket trade after the company reported its contract backlog expanding more quickly than revenue. The stock climbed to $98.28 at 08:03 EDT, up from $83.74 at Thursday’s close, with around 100,000 shares traded ahead of the open.
Elastic investor dashboard
Fiscal Q1 2027 results and premarket repricing
Premarket price
$98.28
Prior close: $83.74
Premarket move
+17.36%
+$14.54 per share
Implied value gain
≈$1.5B
Estimate from quoted market value
Premarket volume
100,194
Shares observed at 08:03 EDT
Growth comparison
Contract visibility
| Operating measure | Reported | Investor read-through |
|---|---|---|
| Adjusted EPS | $0.70 vs $0.58 consensus | Beat supports the rally |
| Q2 revenue midpoint | $486.5M vs $483M consensus | Modest upside to expectations |
| >$100K ACV customers | 1,800 vs 1,550 year ago | Enterprise cohort grew 16% |
| Non-GAAP operating margin | 16.2% | Positive adjusted leverage |
| GAAP operating margin | -5.0% | Profit-quality gap remains |
Why investors care
Current RPO grew six points faster than revenue. That expands near-term contracted visibility if deployments and renewals convert as planned.
What can break the thesis
A slower backlog conversion, rising AI infrastructure costs or stronger cloud competition could expose the gap between adjusted profit and the GAAP loss.
Sources: Elastic fiscal Q1 2027 release; FactSet estimates cited by Investors.com; StockAnalysis premarket quote. Market figures timestamped 28 Aug 2026, 08:03 EDT. Implied value change is an estimate, not a reported company figure.
IREN Shares Drop 5.8% as $684 Million Loss Underscores AI Cloud Strategy Challenges
IREN Limited shares declined by 5.75% ahead of the market open on Friday, cutting approximately $833 million from its implied equity valuation.
IREN: AI Cloud crosses the revenue midpoint
FY2026 results and premarket reset · Market data at 07:14 EDT, August 28, 2026
Premarket price
$38.20
−5.75%
Implied value lost
~$833M
357.38M shares × $2.33
Premarket volume
1.25M
as of 07:14 EDT
Market value
$14.46B
prior-close basis
Quarterly revenue mix flipped
51.4% of Q4 revenue came from AI Cloud; Bitcoin mining supplied 48.6%.
ARR conversion ladder
Contracted ARR
$4.0B
Operating today
$1.0B
Q4 GAAP AI Cloud revenue
$70.5M
ARR is a non-GAAP operating metric. IREN warns recognized revenue may be materially lower. Commissioning and customer acceptance govern conversion.
Operating scorecard
| US$ millions | Q4 | Q3 | Change |
|---|---|---|---|
| Total revenue | 137.2 | 144.8 | −5.2% |
| AI Cloud | 70.5 | 33.6 | +109.8% |
| Bitcoin mining | 66.7 | 111.2 | −40.0% |
| Adjusted EBITDA | 19.2 | 59.5 | −67.7% |
| Net loss | (684.0) | (247.8) | Wider |
Capital architecture
$14B liquidity + commitments
$2.8B GPU financing
90% GPU capex financed
45–55% customer prepayments
Quarter-end cash and restricted cash: $7.62B.
Q4 operating cash flow: $1.81B, including a $1.72B increase in deferred revenue.
Deferred revenue supports cash flow before revenue recognition. It also creates delivery obligations.
Why the shares moved
The market is weighing a fast mix shift against its accounting cost. AI Cloud more than doubled sequentially, but adjusted EBITDA fell 68% and the quarter carried a $450.4M mining-hardware impairment.
The key question is no longer demand alone. It is how quickly contracted ARR becomes recognized revenue without further impairments, delays or financing strain.
Market pressure points
52-week range
$25.31–$76.87
Short interest
30.61% of float
Three-month return
−36.21%
One-year return
+53.06%
Execution milestones
| 2026 IT capacity target | 0.3 GW |
| 2027 IT capacity target | 0.8 GW |
| Horizon 1 | Accepted by Microsoft |
| Recent contract economics | >$20M revenue/MW |
| Claimed payback | ~2 years |
Risks to monitor
Commissioning delaysCustomer concentrationGPU supplyHardware obsolescenceDebt costBitcoin exposure
The $4B contracted ARR figure is not recognized revenue. Timing, utilization, uptime and customer acceptance remain decisive.
Sources: IREN FY2026 results; MarketWatch quote and ownership data; Investors.com market report. Financial figures in U.S. dollars. Calculations may differ due to rounding.
PayPal Shares Drop 15.4% Following Abandoned $53 Billion Acquisition Attempt
SAN JOSE, California, August 28, 2026, 07:02 — PayPal Holdings Inc shares slumped 15.4% after the company called off its pursuit of a $53 billion takeover, prompting investor concerns over its growth strategy.
PayPal · NASDAQ: PYPL
Bid premium disappears; execution takes over
Premarket takeover-reset dashboard
$52.00▼ 15.41%
Aug. 28, 2026 · 06:52 EDT
Value erased*
≈$8.1B
Reported bid
$53B
TTM revenue
$34.13B
TTM net income
$4.90B
Price markers
Reported offer$60.50
Prior close$61.47
Premarket$52.00
Premarket price equals 86% of the reported offer. Shares had gained nearly 30% since the pursuit was reported.
Core question: can PayPal's turnaround deliver growth and margin expansion without merger optionality?
Operating and valuation signals
Shares outstanding855.46M
Forward P/E11.08×
2025 revenue growth4.3%
2025 earnings growth26.2%
Analyst consensusHold
Average target$60.57
Main risksCompetition · execution
Sources: Reuters, PayPal investor relations and StockAnalysis. *Estimated from the $9.47 premarket decline and 855.46 million shares outstanding. Market data is time-sensitive.
DraftKings Shares Drop 2.3% with NFL Reviving Competition with FanDuel Before $30 Billion Season
The NFL has extended its multi-year sportsbook agreements with DraftKings Inc. and Flutter Entertainment plc's FanDuel, and introduced Fanatics, a privately owned company, as its third operator. DraftKings' shares ended Thursday's session at $24.22, a decrease of 2.3%, with 7.42 million shares exchanging hands. In premarket trade at 04:01 EDT Friday, the stock was at $24.44, a gain of 0.9%.
draftkings vs fanduel
NFL distribution is secured; unit economics remain the real contest.
Market data: Aug. 27, 2026 close / Aug. 28, 04:01 EDT
Compiled: Aug. 28, 2026, 04:20 EDT
Compiled: Aug. 28, 2026, 04:20 EDT
DKNG close
$24.22
−2.26%
DKNG premarket
$24.44
+0.91%
NFL legal wagers
$30B
2025 season estimate
2026 kickoff
Sep. 9
First monetization test
DraftKings Q2 operating scorecard
Volume and users expanded, but game outcomes and promotions compressed monetization.
Stock context
The renewal preserved distribution but did not reverse the de-rating.
Operator comparison
| Signal | DraftKings | FanDuel parent Flutter | What matters |
|---|---|---|---|
| Q2 revenue | $1.443B, −5% | $4.326B, +3% groupwide | Growth quality diverged |
| Activity | $13.1B sports volume, +15% | FanDuel retains NFL sportsbook status | Access is broad; conversion decides value |
| Profit signal | FY26 EBITDA guide $700M–$900M | Q2 adjusted EBITDA $508M, −45% | Promotions and taxes pressure margins |
| Market close | $24.22, −2.3% | $95.01, −3.1% | Investors remain cautious |
Why the NFL renewal matters
DraftKings and FanDuel retain promotion, real-time statistics, event presence and NFL digital integrations. DraftKings also keeps daily fantasy status. Fanatics joins as a third sportsbook partner and gains online-casino marketing rights.
Investor checklist
Positive: payer retention and cross-sell. Negative: customer-friendly results or higher acquisition costs.
Intel Stock Rises 4.4% as Nvidia Forecast Revives AI-Chip Demand
Intel Corporation rose 4.36% on Thursday as Nvidia's forecast revived confidence in AI infrastructure spending.
NASDAQ: INTC · AI-demand spillover
Intel gains, but dilution still sets the hurdle
Nvidia's forecast lifted Intel 4.36%; the close remains below Intel's recent $95 share-sale price.
Market data: Aug. 27, 2026, 20:15 EDT
Financials: Q2 2026
Financials: Q2 2026
Close
$92.09
High $92.92 · Low $88.51
Daily move
+4.36%
+$3.85 per share
Volume
100.56M
+32.7% vs. Aug. 26
Market value
$470.0B
About +$19.6B on the day
Five-session Intel close
Why the stock moved
Nvidia move+8.72%AI-spending confidence
Nvidia forecast~70%next-fiscal-year revenue growth
Offering price$95.00Intel close is 3.1% lower
ConsensusHold$114.88 average target
Peer reaction and valuation
| Company | Close | Move | Volume | Trailing P/E |
|---|---|---|---|---|
| Intel | $92.09 | +4.36% | 100.56M | N/M |
| Nvidia | $227.98 | +8.72% | 298.91M | 28.6× |
| AMD | $476.67 | −0.86% | 16.44M | 122.5× |
| Micron | $935.39 | −0.36% | 28.84M | 21.2× |
The split tape matters: Thursday rewarded Intel's AI exposure, but the whole semiconductor group did not rally.
Intel operating scorecard
| Q2 revenue | $16.1B | +25% |
| GAAP gross margin | 40.4% | +12.9 pts |
| GAAP operating margin | 11.1% | +35.8 pts |
| Non-GAAP net income | $2.2B | vs. loss |
| GAAP net result | −$11.0B | loss |
What investors are pricing
Operations improve
Revenue and margins rose sharply, but the GAAP loss kept earnings quality in focus.
$20B equity raise
Intel sold 210.5 million shares at $95, creating a clear dilution and execution benchmark.
AI demand rerates Intel
Nvidia's forecast lifted Intel, yet no new Intel design win was announced.
Investor takeaway
Intel's 4.36% gain says the market sees value in its exposure to expanding AI budgets. The harder test is conversion: foundry utilization, server share, margin durability and cash generation must justify both a $470 billion valuation and the new capital raised at $95.
Brent Climbs 2% to $89.70 as Iran Negotiations Break Down, Oil Prices Surge
Oil prices surged on Thursday as Washington declined to revert to previous Iran deal terms. Brent climbed $1.85 to $89.70, while U.S. West Texas Intermediate increased $1.28, reaching $83.53.
U.S. oil market · market/asset/sector
Iran risk restores the crude premium
Settlement snapshot for August 27, 2026. Updated at 21:06 EDT / August 28, 03:06 CEST.
Brent settlement
$89.70
+2.1%
Aug. 27 close · per barrel
WTI settlement
$83.53
+1.6%
Aug. 27 close · per barrel
Brent–WTI spread
$6.17
7.4% of WTI
International-risk gauge
U.S. crude stocks
428.9M
+0.1M barrels
Week ended Aug. 21 · EIA
Brent versus EIA forecast path
Brent settled 5.5% above EIA's third-quarter average and 15.0% above its fourth-quarter forecast.
Physical-market signals
| Commercial crude stocks | 428.9M bbl 1% above five-year average |
| Weekly crude change | +0.1M bbl |
| Gasoline stocks | −2.5M bbl 6% below five-year average |
| Refinery utilization | 97.4% |
| Refinery inputs | 17.4M b/d |
What moved the market
Aug. 26
EIA reported nearly flat crude stocks but a 2.5-million-barrel gasoline draw.
Aug. 27
Diplomatic optimism faded after reports that Washington rejected earlier Iran deal terms.
Settlement
Brent closed at $89.70 and WTI at $83.53, reversing three declining sessions.
Sep. 2
Next scheduled EIA petroleum report. Inventory confirmation becomes the next domestic catalyst.
Investor transmission
| Channel | Signal |
|---|---|
| Inflation | Upward Higher crude lifts refined-product and freight costs. |
| Airlines & transport | Margin risk Fuel hedges determine near-term sensitivity. |
| Producers | Cash-flow support WTI above $80 strengthens upstream economics. |
| Refiners | Mixed Feedstock rises while gasoline stocks remain tight. |
Risk map
| Scenario | Price pressure | Evidence to watch |
|---|---|---|
| Verified Hormuz corridor | Downward | Higher tanker counts, lower freight and insurance rates. |
| Diplomacy remains stalled | Premium persists | Brent–WTI spread holds above $6. |
| Further military escalation | Sharp upside risk | Supply outages, shipping delays and wider refined-product cracks. |
| Demand disappoints | Offsets risk premium | Inventory builds and weaker refinery runs. |
Sources: Reuters, Aug. 27 settlement; EIA Weekly Petroleum Status Report, Aug. 26; EIA Short-Term Energy Outlook. Values are market snapshots, not forecasts unless labeled.
PagerDuty Shares Dip 0.2% Post-Market; 15% Workforce Reduction Boosts Profit Guidance
SAN FRANCISCO, August 27, 2026, 18:45 EDT — PagerDuty stock eased 0.2% in after-hours trading after the company announced it will cut its workforce by 15%, a move aimed at raising its profit forecast.
PagerDuty · NYSE: PD
Profit improves faster than growth
Cost controls and a 15% workforce reduction lifted the earnings outlook. Revenue grew just 0.8%, leaving shares almost unchanged after hours.
Q2 FY2027Reported Aug. 27, 2026After-hours
$12.60 −0.24%
Regular close: $12.63, +3.61%
17:04 EDT · Aug. 27, 2026
Revenue
$124.4M
+0.8% YoY
GAAP op. margin
8.2%
+530 bp YoY
ARR
$501M
+0.4% YoY
Free cash flow
$32.8M
+8.6% YoY
Growth versus operating leverage
The margin expansion is the dominant signal. Customer and recurring-revenue growth remain modest.
Restructuring
Workforce reduction~15%
Expected charges$5.5M–$7.5M
TimingMainly H2 FY2027
Cash + investments$470.0M
Guidance reset
| Metric | New | Prior | Midpoint change |
|---|---|---|---|
| FY revenue | $491.5M–$496.5M | $488.5M–$496.5M | +0.3% |
| FY adj. EPS | $1.33–$1.37 | $1.27–$1.32 | +4.2% |
| Q3 revenue | $123M–$125M | — | New |
| Q3 adj. margin | 26.5%–27.5% | — | New |
Customer and valuation signals
Net retention98%
$100K+ ARR customers884
Paid customers15,506
Average analyst target$10.64
AH premium to target18.4%
Investor read-through
Bull case: The restructuring protects cash generation and supports a higher EPS range. Q2 beat revenue guidance, and free cash flow improved.
Bear case: ARR grew only 0.4% and retention stayed below 100%. The stock already trades above the average analyst target.
Watch next: Q3 revenue of $123M–$125M, adjusted margin of 26.5%–27.5%, retention and the pace of restructuring charges.
Market data: MarketWatch, 17:04 EDT, Aug. 27, 2026. Financials and guidance: PagerDuty Q2 FY2027 release. Analyst target: Investing.com. After-hours prices may change on limited liquidity.
Marvell Shares Drop 7.6% After Hours Even as Revenue Hits Record $2.74 Billion
SANTA CLARA, August 27, 2026, 18:05 — Marvell Technologies stock slid 7.6% in after-hours trading, despite the company reporting record quarterly revenue of $2.74 billion.
NASDAQ: MRVL · Earnings reaction
Marvell: record quarter, higher expectations
Market data: Aug. 27, 2026, 18:00 EDT
Financials: Q2 FY2027
Financials: Q2 FY2027
After-hours price
$223.05
−7.62% from $241.45 close
Market value erased
≈$16.1B
Based on $211.73B regular-close cap
Q2 revenue
$2.739B
+37% year over year
Regular volume
38.9M
1.66× recent average
AI data-center concentration
$2.17B · 79.2% of sales
Data-center revenue grew 46% year over year.
Why shares fell
The fundamentals beat estimates, but not elevated AI expectations. Q3 revenue guidance exceeded consensus by about 4%, while the non-GAAP gross-margin midpoint falls 90 basis points sequentially.
Quarterly operating picture
| Metric | Q2 FY26 | Q2 FY27 | YoY |
|---|---|---|---|
| Revenue | $2.006B | $2.739B | +36.5% |
| GAAP operating income | $290.1M | $459.7M | +58.5% |
| GAAP gross margin | 50.4% | 53.1% | +270 bp |
| Operating cash flow | — | $605.5M | — |
Q3 outlook versus consensus
| Metric | Guide midpoint | Consensus | Premium |
|---|---|---|---|
| Revenue | $3.15B | $3.03B | +4.0% |
| Adjusted EPS | $1.10 | $1.07 | +2.8% |
| Non-GAAP gross margin | 58.0% | — | −90 bp QoQ |
Revenue midpoint implies roughly 15% sequential growth.
Cash
$3.93B
Quarter-end balance
Long-term debt
$4.96B
Up from $3.97B in January
R&D
$741.1M
+43% year over year
Stock compensation
$326.2M
More than doubled YoY
Investor timeline
Aug. 27Q2 results and Q3 guidance
After hoursShares fall 7.62%
Oct. 6Investor day: long-term AI roadmap
Watch: custom-silicon ramps, optical demand, customer concentration, supply, gross-margin conversion and cash returns.
IREN Shares Drop 6% After Hours as AI Shift Spurs $639 Million Write-down
Shares of IREN Limited dropped 5.97% in after-hours trading on Thursday. Despite strong expansion in AI Cloud, the costs from infrastructure transition and associated accounting impacts weighed on the company.
IREN investor dashboard
FY26 transition to AI Cloud • Market data at August 27, 2026, 18:00 EDT
After-hours price
$38.11
-$2.42 • -5.97%
FY26 revenue
$707.0M
+41.1% YoY
AI Cloud revenue
$128.8M
~7.9× YoY
FY26 net loss
-$702.6M
$638.8M impairment
Revenue mix shift
AI Cloud rose from 3.3% to 18.2% of annual revenue.
Contracts and capacity
| Operating ARR | $1.0B |
| Contracted 2026 ARR | $4.0B |
| 2026 IT capacity | ~0.3GW |
| 2027 IT capacity target | ~0.8GW |
| Recent revenue / MW | >$20M |
| Customer prepayments | 45–55% GPU capex |
ARR is a non-GAAP operating metric. Recognized revenue may be materially lower.
Financial bridge
| Metric | FY25 | FY26 | Change |
|---|---|---|---|
| Total revenue | $501.0M | $707.0M | +41.1% |
| AI Cloud revenue | $16.4M | $128.8M | +685% |
| Adjusted EBITDA | $269.7M | $245.7M | -8.9% |
| Net income/(loss) | $86.9M | -$702.6M | NM |
Market and analyst view
| Regular close | $40.53 |
| After-hours | $38.11 |
| Implied value change | ~-$865M |
| 52-week range | $22.63–$76.87 |
| Ratings | 7 Buy / 2 Hold / 1 Sell |
| Average target | $77.44 |
Investor read-through
AI demand validatedLegacy mining impairmentHeavy external financingExecution riskWatch: quarterly adjusted EBITDA fell 67.7% sequentially as staffing and platform costs arrived before the revenue ramp. Deferred revenue drove $1.722 billion of quarterly operating cash flow.
Sources: IREN FY26 results; Public after-hours data; Google Finance. Extended-hours prices may change before the next regular session.
Workday Shares Drop 7.0% in After-Hours Trading After Subscription Revenue Forecast Misses Expectations
PLEASANTON, California, August 27, 2026, 17:30 – Workday shares fell 7.0% in after-hours trading after the company issued a subscription revenue outlook of $2.52 billion that fell short of analyst estimates.
NASDAQ: WDAY · Fiscal Q2 2027 earnings reaction
Workday: AI traction meets a growth ceiling
Market snapshot: August 27, 2026, 17:30 EDT · Quarter ended July 31
After-hours price
$179.99
−$13.58 · −7.02%
Regular close
$193.57
Volume: 7.36M
Q2 revenue
$2.649B
+12.8% YoY
Adjusted EPS
$2.75
+$0.14 vs consensus
What cleared the bar—and what did not
Q2 revenue+$13M
Q2 adj. EPS+$0.14
FY sub midpoint+$7.5M
Q3 subscriptionsIn line
Bar lengths are normalized within each comparison, not a common scale.
AI adoption
Guidance and capital return
| Metric | Current | Investor signal |
|---|---|---|
| Q3 subscription revenue | ~$2.515B | Broadly in line |
| FY subscription revenue | $9.94–$9.95B | Tiny midpoint raise |
| New buyback authorization | $4.0B | ~9% of AH value |
| After-hours value loss | ~$3.3B | 7.02% move |
Street view
| Consensus | Outperform |
| Analysts | 41 |
| Average target | $188.21 |
| Median target | $202.00 |
| Target range | $92–$275 |
| Upside to average | 4.6% |
Watch enterprise IT budgets, large-deal timing, AI pricing, Financials adoption and acquisition speculation. Extended-hours liquidity can amplify the move.
Sources: Workday, Reuters, WSJ, Public and MarketScreener.Prices: 17:30 EDT. Financials: reported August 27, 2026.
Rubrik Shares Fall 9.3% After Hours; Company Beats Revenue Estimates by $31 Million
Rubrik shares fell significantly after the bell, even though the company reported much stronger earnings than expected. The reaction suggested investors had already anticipated the positive developments.
Rubrik Q2 FY2027 investor dashboard
Market data: August 27, 2026, 5:00 p.m. EDT · Financial data: quarter ended July 31, 2026
After-hours
$97.12
−9.25% from $107.02 close
Regular session
+11.33%
6.36M shares vs 3.60M 65-day average
Q2 revenue
$427.3M
+38% YoY · about $31M above consensus
Subscription ARR
$1.66B
+33% YoY · Cloud ARR +39%
Beat versus pre-report consensus
Operating quality
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | $427.3M | $309.9M | +38% |
| Subscription ARR margin | 14.0% | 9.4% | +4.6 pp |
| Non-GAAP gross margin | 81.0% | 81.6% | −0.6 pp |
| Free cash flow | $65.7M | $57.5M | +14% |
| FCF margin | 15% | 19% | −4 pp |
Raised fiscal 2027 outlook
| Metric | Prior range | New range | Midpoint lift |
|---|---|---|---|
| Revenue | $1.638B–$1.648B | $1.685B–$1.693B | +$46M |
| Subscription ARR | $1.854B–$1.862B | $1.880B–$1.885B | +$24.5M |
| Free cash flow | $293M–$303M | $323M–$333M | +$30M |
| Adjusted EPS | $0.25–$0.35 | $0.47–$0.53 | +$0.20 |
Investor bridge
The $30 million free-cash-flow midpoint increase is a 10.1% lift, while the $46 million revenue midpoint increase is 2.8%. The after-hours reversal says expectations rose faster than the outlook.
3,084 large customers+23% YoY$1.75B liquidity
Valuation and expectations
$105.63
Average analyst target before the report; about 8.8% above the 5:00 p.m. after-hours price. The stock touched a record $107.91 intraday and had gained roughly 85% over six months.
Risks to monitor
Extended-hours liquidity can distort price discovery. Rubrik remains GAAP-loss-making. Non-GAAP gross margin slipped 0.6 point, free-cash-flow margin fell four points, and a record-high setup leaves little room for execution misses.
Sources: Rubrik/Business Wire results, Rubrik prior guidance, Public after-hours data, WSJ market data and Yahoo Finance analyst data. Figures are company-reported unless otherwise stated.
Sarepta Stock Jumps 13%, but Elevidys Safety Study Slips Five Months
CAMBRIDGE, Mass., Aug. 27, 2026, 3:16 p.m. EDT — Shares of Sarepta Therapeutics rose 12.9% to $21.98 on Thursday, trading near the session high of $22.57. About 5.94 million shares had changed hands, versus a recent daily average of roughly 3.2 million.
SRPT event dashboard · Aug. 27, 2026
Sarepta rally meets an ENHANCE timeline delay
Market snapshot: 3:16 p.m. EDT. The stock move is large; the verified registry change is procedural and includes a five-month completion delay.
SRPT price
$21.98
Range $18.78–$22.57
Day move
+12.95%
≈ $265m equity value added
Volume
5.94m
≈ 1.9× recent average
Market cap
$2.32b
Intraday snapshot
What actually changed in ENHANCE
| Registry field | Before | Aug. 26 update |
|---|---|---|
| Site footprint | Original site set | Baylor College of Medicine added |
| Recruitment | Not yet recruiting | Unchanged |
| Enrollment | 20 | Unchanged |
| Estimated start | Jul. 31, 2026 | Aug. 31, 2026 |
| Primary/final completion | Mar. 31, 2027 | Aug. 31, 2027 |
Signal quality:
No new efficacy or safety result, no first-patient milestone, no FDA decision and no new Sarepta press release. The added site is constructive; the schedule slipped.
No new efficacy or safety result, no first-patient milestone, no FDA decision and no new Sarepta press release. The added site is constructive; the schedule slipped.
Q2 revenue reset
Balance-sheet pressure points
Cash + investments
$945.0m
Debt, carrying value
$847.6m
Inventory
$1.13b
Manufacturing commitments
$428.0m
Rally amplifier vs. fundamental risk
AMPLIFIER
~27% of float sold short
~27% of float sold short
CATALYST
Baylor site added
Baylor site added
TIMELINE
Completion +5 months
Completion +5 months
SAFETY
Elevidys boxed warning
Elevidys boxed warning
DEMAND
Elevidys Q2 revenue −65%
Elevidys Q2 revenue −65%
Scenario monitor
| Path | Confirmation signal | What would challenge it |
|---|---|---|
| Bull | Recruitment begins; FDA pathway gains clarity; short covering persists | Further trial slippage or weak dosing demand |
| Base | Registry edit stays procedural; shares consolidate into the next data event | Company-specific disclosure changes the evidence set |
| Bear | Delay and safety concerns dominate; squeeze fades | Fast activation plus credible label-expansion progress |
Sources: ClinicalTrials.gov,
Sarepta Form 10-Q,
Sarepta IR, and market data snapshot at 3:16 p.m. EDT. Short-interest figures are the latest published estimate and can lag. This dashboard separates verified disclosures from market inference.
Take-Two Shares Slip 2.1% With Netflix Preview of GTA VI Marking Final Launch Phase
Take-Two Interactive Software stock declined 2.12% while Rockstar Games initiated its last marketing campaign for Grand Theft Auto VI.
Product / commercial catalyst
Grand Theft Auto VI: the launch funnel
Take-Two Interactive Software · NASDAQ: TTWO
Market data: Aug. 27, 2026, 13:04 EDT
Product and company data: Aug. 27, 2026
Product and company data: Aug. 27, 2026
TTWO price
$228.50
−2.12% · −$4.95
Market value
$42.73B
~$920M erased today
GTA VI base price
$79.99
PS5 · Xbox Series X|S
FY2027 bookings
$8.0–8.2B
Midpoint +20.5% vs FY2026
Company bookings step-up
The FY2027 range is company-wide. It includes GTA VI, NBA 2K, mobile titles and other releases; it is not a GTA VI sales forecast.
Market snapshot
Day range$226.55–237.77
Volume1.52M
Analyst target$296.9522 analysts
Implied upside29.9%MarketBeat consensus
Moderate Buy Analyst targets remain sensitive to launch timing and online monetization.
Four gates between attention and recognized revenue
Netflix premierePaid-platform first window
Public video releaseYouTube and Rockstar site
Game launch$79.99 base edition
Online economicsKey long-tail valuation test
Operating bridge
| Metric | Latest | Signal |
|---|---|---|
| Q1 FY2027 bookings | $1.39B | −3% year on year; slightly above guidance |
| Recurrent consumer spending | 84% of bookings | −1% year on year |
| FY2026 bookings | $6.72B | Baseline before GTA VI launch year |
| GTA V installed base | >230M units | Proof of franchise durability |
| GTA VI pre-orders | “Unprecedented” | Management description; not yet recognized sales |
What today's move says
Search attention and the showcase are strong. The stock still fell 2.12%, suggesting investors want execution evidence, not another anticipation cycle.
At $228.50, the market discounts roughly 30% upside to the analyst target. That spread also embeds delay, launch-quality and mobile-performance risk.
Risk board
TimingAnother delay would push bookings and marketing costs across fiscal periods.
ConversionPre-orders measure intent. Cancellations and edition mix determine realized revenue.
Online modelLong-term value depends on engagement and spending after launch.
PortfolioMobile weakness can offset strength from GTA and NBA 2K.
Sources: Rockstar Games; Take-Two fiscal Q1 2027 results and pre-order release; Reuters; MarketBeat; intraday U.S. market data. Figures are as timestamped and may change.
Strategy Stock Rises 12%, Surges Ahead of Bitcoin Four Times as BTC Hits $80,000
Strategy stock surged 12% on Thursday after bitcoin topped $80,000. The equity posted a gain nearly four times higher than the cryptocurrency's daily return.
NASDAQ: MSTR · BITCOIN TREASURY
Equity leverage returns as bitcoin clears $80,000
Market: Aug. 27, 2026, 11:53 ET
Holdings and liquidity: Aug. 23, 2026
Holdings and liquidity: Aug. 23, 2026
MSTR price
$137.95
+$14.76 · +12.0%
Bitcoin
$80,367
+$2,262 · +2.9%
Bitcoin held
840,447
4.0% of maximum supply
Dollar liquidity
$6.69B
Reserve + flexible cash
One-day return: common stock versus bitcoin
The common stock added roughly $5.2 billion of quoted value. The bitcoin reserve gained about $1.9 billion at the same snapshot.
Reserve sensitivity
Gross bitcoin value
$67.5B
Unrealized gross gain
≈$4.2B
Value change per $1,000 BTC move
≈$840M
Before debt, preferred equity, tax and other claims.
Capital structure and operating signals
| Measure | Reading | Why it matters |
|---|---|---|
| BTC acquisition cost | $63.36B / $75,385 each | Current token price sits 6.6% higher |
| USD Reserve | $5.10B | Supports dividends and interest |
| USD Cash | $1.59B | Flexible treasury deployment |
| Q2 long-term debt | $6.7B | Down 18% in the quarter |
| Q2 preferred equity | $14.4B | Senior claim to common stock |
| Q2 software revenue | $122.4M | Up 6.9% year over year |
Latest capital allocation
| Action, Aug. 17–23 | Amount | Investor interpretation |
|---|---|---|
| MSTR shares sold | 18.26M | Common-stock dilution |
| Net proceeds | $2.0065B | About $109.88 per share |
| STRC repurchase | $136.4M | Reduces preferred claim |
| USD Reserve increase | $300M | Extends obligation coverage |
| Bitcoin traded | None | 840,447 BTC unchanged |
Analyst markers
Canaccord
$175
Buy · raised Aug. 25
Bernstein
$350
Outperform · cut Aug. 26
Risk frame
MSTR’s daily gain materially exceeded bitcoin’s. That leverage can reverse. Common issuance, preferred dividends, debt service, tax changes, regulation and contraction of the equity multiple can outweigh a stable token price.
Primary data: Strategy Aug. 24 Form 8-K and Q2 2026 results. Market data timestamped above.
ServiceNow Shares Surge 9%—$11.7 Billion Gain Linked to Salesforce AI Results Shifting Software Valuations
SANTA CLARA, California, August 27, 2026, 10:37 EDT — ServiceNow's stock soared 9%, translating to an added $11.7 billion in market value as Salesforce's recent AI-driven financial results sparked a broad revaluation of software sector stocks.
NYSE: NOW · Stock move
ServiceNow re-rating dashboard
Salesforce's AI results pulled enterprise software higher.
Market snapshot
Aug. 27, 2026 · 10:37 EDT
Aug. 27, 2026 · 10:37 EDT
NOW price
$137.16
+9.03% · +$11.36
Value created
≈$11.7B
Based on 1.03B shares
Volume
10.52M
64.7% of 20-day average by 10:37
Consensus upside
3.7%
$142.23 average target
The gap compressed
What powered the move
Salesforce stock+20.75%
Agentforce + Data 360 ARR$3.9B · +210%
Agentforce ARR>$1.5B · +240%
FY27 revenue outlook$46.1B-$46.4B
Salesforce market data at 10:28 EDT; operating metrics released Aug. 26.
ServiceNow operating engine
Q2 subscription revenue$3.877B · +24.5%
Q2 cRPO$13.20B · +21%
Q2 RPO$29.0B · +21%
FY26 subscription guide$15.760B-$15.780B
FY26 FCF margin guide35%
Valuation and expectations
Market capitalization$141.80B
Forward P/E27.76×
Forward price/sales7.36×
EV/free cash flow28.78×
Analyst ratingStrong Buy · 49 analysts
Software read-through
| Company | Price | Move |
|---|---|---|
| ServiceNow (NOW) | $137.16 | +9.03% |
| Salesforce (CRM) | $248.29 | +20.75% |
| Workday (WDAY) | $197.39 | +3.48% |
| Oracle (ORCL) | $150.84 | +1.32% |
NOW at 10:37 EDT; peer prices at about 10:28 EDT on Aug. 27, 2026.
Near-term checks
2:40 p.m. EDT today
ServiceNow CFO Gina Mastantuono speaks at Deutsche Bank's technology conference.
Next quarter
Watch whether cRPO holds near 20% constant-currency growth and AI ACV converts into subscriptions.
Risk
The rally is a peer read-through. Average target upside is now only 3.7%.
Trend context, correctly dated
The U.S. search phrase “now stock” also points to ServiceNow's expanded Tech Mahindra partnership. It was announced Aug. 20, not today. Tech Mahindra says its ServiceNow deployment handles more than 100,000 monthly cases across 90 countries, supports 150,000 employees and has optimized about 25% of first-level support work.
Revenue and bookings proofValuation re-ratingExecution checkpoint
Micron Shares (MU) Retreat Nearly Entirely After Nvidia Surge, $1,300 Target Remains in Play
BOISE, Idaho, August 27, 2026, 09:39 EDT — Micron Technology's stock has erased 82% of its Nvidia-driven opening gap, with attention staying on its projected $1,300 price target.
Google Trend: MU · NASDAQ:MU
Micron’s Nvidia gap faded fast
The AI-memory read-through remains strong. Price action says investors still want Micron-specific proof on HBM volume, pricing and margins.
Market open · 09:39 EDT
Micron price
$943.46
+$5.06 · +0.54%
Opening gap
+3.05%
82% erased by 09:39
$1,300 target
+37.8%
8.4× FY2027 EPS estimate
Analyst consensus
$1,515
Strong Buy · 47 analysts
Ten-session price path
August 27 value is intraday at 09:39 EDT; earlier values are official closes. The stock opened at $967.01 before fading.
Fundamentals and valuation
| Metric | Current / latest | Comparison | Investor reading |
|---|---|---|---|
| Fiscal Q3 revenue | $41.46B | $23.86B prior quarter | +73.8% sequential |
| Operating cash flow | $25.39B | $11.90B prior quarter | Cash conversion strengthened |
| Adjusted free cash flow | $18.3B | $7.1B capex | Funds expansion internally |
| Adjusted gross margin | 84.9% | 74.9% prior quarter | Exceptional, hard to sustain |
| Forward P/E | 6.5× | 21.2× trailing | Large earnings-cycle assumption |
| Net cash | $23.75B | $21.03 per share | Balance-sheet cushion |
AI-memory transmission chain
Nvidia Q2 revenue
$96.2B
+106% year over year
Data-center revenue
$89.0B
+117% year over year
Nvidia Q3 outlook
$108B
±2%; excludes China compute
Micron HBM4
>2.8 TB/s
36GB 12-high; Rubin design
HBM is stacked memory placed beside AI accelerators. Higher accelerator shipments increase the addressable memory content, but Micron’s realized revenue still depends on qualification, allocation, pricing and yield.
Targets and next check
| Reference | Target / value | Upside from $943.46 | Implied FY2027 P/E |
|---|---|---|---|
| Current price | $943.46 | — | 6.1× |
| BMO / Mizuho | $1,300 | 37.8% | 8.4× |
| Analyst average | $1,515 | 60.6% | 9.8× |
| Analyst low | $361 | −61.7% | 2.3× |
| Analyst high | $2,200 | +133.2% | 14.2× |
Next dated catalyst: Micron reports fiscal fourth-quarter results on September 30 at 2:30 p.m. Mountain time. Watch HBM shipments, memory pricing, gross margin and fiscal 2027 capex.
Main risk: A slower AI-server buildout, weaker HBM pricing or faster rival capacity additions could compress the earnings estimate that makes Micron appear inexpensive.
TechStock² Updates
